EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Mutant IDH regulates glycogen metabolism from early cartilage development to malignant chondrosarcoma formation

Sinthu Pathmanapan, Raymond Poon, Tomasa Barrientos De Renshaw, Puviindran Nadesan, Makoto Nakagawa, Gireesh A Seesankar, Adrian Kwan Ho Loe, Hongyuan H Zhang, Joan J Guinovart, Jordi Duran, Christopher B Newgard, Jay S Wunder und 1 weitere

Cell Reports · 2023

DOI: 10.1016/j.celrep.2023.112578 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2023. Verfasst von Sinthu Pathmanapan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Developmental and Stem Cell Biology, Hospital for Sick Children, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, O…. Hauptthemen laut MEDLINE: Chondroma, Chondrosarcoma, Isocitrate Dehydrogenase. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAMS NIH HHS, National Institutes of Health, Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChondromaChondrosarcomaIsocitrate DehydrogenaseAnimalsHumansMiceBone NeoplasmsCartilageMutation

Stichwörter der Autor:innen

CP: CancerCP: Metabolismcancerchondrosarcomadevelopmentgenetic mutationglycogenmetabolismmutant IDH

Substanzen

Isocitrate Dehydrogenase

Autor:innen und Institutionen

  • Developmental and Stem Cell Biology, Hospital for Sick Children, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada.
  • Developmental and Stem Cell Biology, Hospital for Sick Children, Toronto, ON, Canada.
  • Department of Orthopaedic Surgery, Duke University, Durham, NC, USA.
  • Institute for Research in Biomedicine (IRB Barcelona) Barcelona, Barcelona, Spain.
  • Department of Pharmacology & Cancer Biology, Duke University, Durham, NC, USA; Sarah W. Stedman Nutrition and Metabolism Center and Duke Molecular Physiology Institute, Duke University Medical Center, Durham, NC, USA.
  • Lunenfeld-Tanenbaum Research Institute and the University Musculoskeletal Oncology Unit, Mount Sinai Hospital, Toronto, ON, Canada.

Förderung

  • NIAMS NIH HHS
  • National Institutes of Health
  • Canadian Institutes of Health Research

Zitieren

APA

Pathmanapan, S., Poon, R., De Renshaw, T. B., Nadesan, P., Nakagawa, M., Seesankar, G. A., Ho Loe, A. K., Zhang, H. H., Guinovart, J. J., Duran, J., Newgard, C. B., Wunder, J. S., & Alman, B. A. (2023). Mutant IDH regulates glycogen metabolism from early cartilage development to malignant chondrosarcoma formation. Cell Reports. https://doi.org/10.1016/j.celrep.2023.112578

Vancouver

Pathmanapan S, Poon R, De Renshaw TB, Nadesan P, Nakagawa M, Seesankar GA, et al. Mutant IDH regulates glycogen metabolism from early cartilage development to malignant chondrosarcoma formation. Cell Reports. 2023. doi:10.1016/j.celrep.2023.112578

BibTeX
@article{Pathmanapan2023,
  author = {Pathmanapan, Sinthu and Poon, Raymond and De Renshaw, Tomasa Barrientos and Nadesan, Puviindran and Nakagawa, Makoto and Seesankar, Gireesh A and Ho Loe, Adrian Kwan and Zhang, Hongyuan H and Guinovart, Joan J and Duran, Jordi and Newgard, Christopher B and Wunder, Jay S and Alman, Benjamin A},
  title = {Mutant IDH regulates glycogen metabolism from early cartilage development to malignant chondrosarcoma formation},
  journal = {Cell Reports},
  year = {2023},
  doi = {10.1016/j.celrep.2023.112578}
}
Kostenlos starten →